Related references
Note: Only part of the references are listed.PET in the Clinical Management of Glioma: Evidence Map
Takashi Nihashi et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2013)
Response assessment of bevacizumab in patients with recurrent malignant glioma using [F-18]Fluoroethyl-l-tyrosine PET in comparison to MRI
Norbert Galldiks et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
18F-AFETP, 18F-FET, and 18F-FDG Imaging of Mouse DBT Gliomas
Kiran Kumar Solingapuram Sai et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
The Use of O-(2-18F-Fluoroethyl)-L-Tyrosine PET for Treatment Management of Bevacizumab and Irinotecan in Patients with Recurrent High-Grade Glioma: A Cost-Effectiveness Analysis
Alexander Heinzel et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Irinophore C™, a lipid-based nanoparticulate formulation of irinotecan, is more effective than free irinotecan when used to treat an orthotopic glioblastoma model
M. Verreault et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Transport of 3-Fluoro-L-α-Methyl-Tyrosine by Tumor-Upregulated L-Type Amino Acid Transporter 1: A Cause of the Tumor Uptake in PET
Pattama Wiriyasermkul et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-L-Tyrosine PET in Comparison to MRI
Norbert Galldiks et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Comparison of 3′-deoxy-3′-[18F]fluorothymidine PET and O-(2-[18F]fluoroethyl)-L-tyrosine PET in patients with newly diagnosed glioma
Su Young Jeong et al.
NUCLEAR MEDICINE AND BIOLOGY (2012)
Relation of LAT1/4F2hc expression with pathological grade, proliferation and angiogenesis in human gliomas
Zhen Haining et al.
BMC CLINICAL PATHOLOGY (2012)
Importance of Attenuation Correction (AC) for Small Animal PET Imaging
Henrik H. El Ali et al.
DIAGNOSTICS (2012)
Discrepant MR and [18F] Fluoroethyl-L-Tyrosine PET Imaging Findings in a Patient with Bevacizumab Failure
Norbert Galldiks et al.
CASE REPORTS IN ONCOLOGY (2012)
A micro-PET/CT approach using O-(2[18F]fluoroethyl)-L-tyrosine in an experimental animal model of F98 glioma for BNCT
L. Menichetti et al.
APPLIED RADIATION AND ISOTOPES (2011)
Advances in MRI Assessment of Gliomas and Response to Anti-VEGF Therapy
Whitney B. Pope et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2011)
Maintenance of EGFR and EGFRvIII expressions in an in vivo and in vitro model of human glioblastoma multiforme
Marie-Therese Stockhausen et al.
EXPERIMENTAL CELL RESEARCH (2011)
O-(2-18F-Fluoroethyl)-L-Tyrosine PET Predicts Failure of Antiangiogenic Treatment in Patients with Recurrent High-Grade Glioma
Markus Hutterer et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Synthesis, uptake mechanism characterization and biological evaluation of F-18 labeled fluoroalkyl phenylalanine analogs as potential PET imaging agents
Limin Wang et al.
NUCLEAR MEDICINE AND BIOLOGY (2011)
Antitumor Effect of NK012, a 7-Ethyl-10-Hydroxycamptothecin-Incorporating Polymeric Micelle, on U87MG Orthotopic Glioblastoma in Mice Compared with Irinotecan Hydrochloride in Combination with Bevacizumab
Jun-ichiro Kuroda et al.
CLINICAL CANCER RESEARCH (2010)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2
Eva M. del Amo et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Recommendations on the use of F-18-FDG PET in oncology
James W. Fletcher et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
FET PET for the evaluation of untreated gliomas:: correlation of FET uptake and uptake kinetics with tumour grading
Gabriele Poepperl et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data
Jan Hellemans et al.
GENOME BIOLOGY (2007)
Mouse models of brain tumors and their applications in preclinical trials
Elena I. Fomchenko et al.
CLINICAL CANCER RESEARCH (2006)
O-(2-[18F]fluoroethyl)-L-tyrosine:: uptake mechanisms and clinical applications
KJ Langen et al.
NUCLEAR MEDICINE AND BIOLOGY (2006)
Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model
HE Wang et al.
NUCLEAR MEDICINE AND BIOLOGY (2005)
System L-amino acid transporters are differently expressed in rat astrocyte and C6 glioma cells
DK Kim et al.
NEUROSCIENCE RESEARCH (2004)
Value of O-(2-[18F]fluoroethyl)-L-tyrosine PET for the diagnosis of recurrent glioma
G Pöpperl et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas
KJ Langen et al.
NUCLEAR MEDICINE AND BIOLOGY (2003)
Share Paper
